Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Covista Inc.
CVSA
NYSE·Consumer Cyclical·Personal Products & Services·Mkt cap $4.4B
$129.88
▲ +1.29%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$86.97 - $156.26
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 5.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Established brand reputation in nursing and healthcare education with 50+ years of experience
- Accredited degree programs with strong employer recognition and graduate outcomes
- Scalable online learning infrastructure serving geographically diverse student populations
- Strategic focus on high-demand healthcare fields with strong job market demand
Bear Case
2 risks
- Low volatility (beta 0.6).
- Premium valuation to Professional Services peers
Growth
Stable outlook
Rising demand for qualified nursing and healthcare professionals nationwide
Value
Premium valuation to Professional Services peers
Momentum
Strong
+8.8% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying CVSA right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 6, 2026
MAY 7, 2026
Reported EPS of $1.98 vs $1.73 consensus (+14.4% surprise). Revenue of $487.0M vs $474.0M expected (+2.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+14.4%
Next: Aug 6, 2026
Revenue trend · last 8Q
—
—
—
—
+13%
+12%
+11%
+12%
Q3 24
Q4 24
Q1 24
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
$412.7M
$409.9M
$417.4M
$447.7M
$466.1M
$457.1M
$462.3M
$503.4M
Margins · last 8Q
Gross
59.2%
Operating
22.1%
Profit
15.2%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$140.00
▲ +7.8% vs $129.88
Latest: Truist · $140.00 · May 11, 2026
1 analyst covering